To validate the finding in vitro, we constructed ESR1 or ESR2-overexpressed PAAD cell lines and then used chemotaxis assays to evaluate the influence of ERs expression on CD8+T-cell migration. The gene discussed is CD8A; the disease is pancreatic adenocarcinoma.